JP2022541125A5 - - Google Patents

Info

Publication number
JP2022541125A5
JP2022541125A5 JP2021577528A JP2021577528A JP2022541125A5 JP 2022541125 A5 JP2022541125 A5 JP 2022541125A5 JP 2021577528 A JP2021577528 A JP 2021577528A JP 2021577528 A JP2021577528 A JP 2021577528A JP 2022541125 A5 JP2022541125 A5 JP 2022541125A5
Authority
JP
Japan
Prior art keywords
treatment
pharmaceutical composition
subject
classifier
tnf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021577528A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022541125A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/039991 external-priority patent/WO2020264426A1/en
Publication of JP2022541125A publication Critical patent/JP2022541125A/ja
Publication of JP2022541125A5 publication Critical patent/JP2022541125A5/ja
Pending legal-status Critical Current

Links

JP2021577528A 2019-06-27 2020-06-26 患者を層別化するための分類子の開発 Pending JP2022541125A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962867853P 2019-06-27 2019-06-27
US62/867,853 2019-06-27
US201962882402P 2019-08-02 2019-08-02
US62/882,402 2019-08-02
US202062965486P 2020-01-24 2020-01-24
US62/965,486 2020-01-24
PCT/US2020/039991 WO2020264426A1 (en) 2019-06-27 2020-06-26 Developing classifiers for stratifying patients

Publications (2)

Publication Number Publication Date
JP2022541125A JP2022541125A (ja) 2022-09-22
JP2022541125A5 true JP2022541125A5 (enExample) 2023-05-30

Family

ID=74061318

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021577528A Pending JP2022541125A (ja) 2019-06-27 2020-06-26 患者を層別化するための分類子の開発

Country Status (11)

Country Link
US (5) US11195595B2 (enExample)
EP (1) EP3990656B1 (enExample)
JP (1) JP2022541125A (enExample)
KR (1) KR20220044720A (enExample)
CN (1) CN114402084A (enExample)
AU (1) AU2020308906A1 (enExample)
CA (1) CA3145237A1 (enExample)
GB (1) GB2603294A (enExample)
IL (1) IL289304A (enExample)
MX (1) MX2022000128A (enExample)
WO (1) WO2020264426A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019178546A1 (en) 2018-03-16 2019-09-19 Scipher Medicine Corporation Methods and systems for predicting response to anti-tnf therapies
US12548678B2 (en) 2020-05-14 2026-02-10 Ampel Biosolutions, Llc Methods and systems for machine learning analysis of single nucleotide polymorphisms in lupus
JP2022541125A (ja) 2019-06-27 2022-09-22 サイファー メディシン コーポレーション 患者を層別化するための分類子の開発
WO2022051245A2 (en) * 2020-09-01 2022-03-10 Scipher Medicine Corporation Methods and systems for predicting response to anti-tnf therapies
US11430575B2 (en) * 2020-11-13 2022-08-30 Specialty Diagnostic (SDI) Laboratories, Inc. Systems and methods for a data driven disease test result prediction
US12271832B2 (en) * 2021-02-12 2025-04-08 Tempus Ai, Inc. Artificial intelligence engine for directed hypothesis generation and ranking
EP4308732A4 (en) * 2021-03-19 2025-02-26 Scipher Medicine Corporation METHODS FOR CLASSIFICATION AND TREATMENT OF PATIENTS
WO2022240875A1 (en) 2021-05-13 2022-11-17 Scipher Medicine Corporation Assessing responsiveness to therapy
US20220399092A1 (en) * 2021-06-10 2022-12-15 Rajant Health Inc. Ai-enabled health platform
EP4359567A4 (en) * 2021-06-22 2025-06-11 Scipher Medicine Corporation METHODS AND SYSTEMS FOR THERAPY MONITORING AND EXPERIMENTAL CONDUCT
WO2023150731A2 (en) * 2022-02-04 2023-08-10 Scipher Medicine Corporation Systems and methods for predicting response to anti-tnf therapies
CN114861764B (zh) * 2022-04-11 2024-11-22 中国科学院计算技术研究所 基于auc优化的多类别分类方法及系统
CN115206439B (zh) * 2022-05-20 2025-07-18 南开大学 跨语言平台的空间转录组数据转换方法及系统
WO2024081737A1 (en) * 2022-10-12 2024-04-18 Exagen Inc. Biomarker selection for machine learning enabled prediction of treatment response
CN116312796B (zh) * 2022-12-27 2023-11-14 江苏先声医学诊断有限公司 一种基于期望最大化算法的宏基因组丰度估计方法及系统
EP4720125A1 (en) 2023-05-30 2026-04-08 Paragon Therapeutics, Inc. Alpha4beta7 integrin antibody compositions and methods of use
EP4762093A1 (en) 2023-08-14 2026-06-24 Paragon Therapeutics, Inc. Alpha 4 beta 7 integrin binding proteins and methods of use
WO2026128869A1 (en) * 2024-12-12 2026-06-18 Palisade Bio, Inc. Companion diagnostic methods of administering pde4 inhibitors

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040120952A1 (en) 2000-08-07 2004-06-24 Centocor, Inc Anti-TNF antibodies and peptides of human tumor necrosis factor
EP2161348A1 (en) 2005-09-27 2010-03-10 Source MDX Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis
TW201337266A (zh) 2005-11-01 2013-09-16 Abbott Biotech Ltd 利用生物標記診斷關節黏連脊椎炎之方法及組合物
US20080026485A1 (en) * 2006-04-18 2008-01-31 Wolfgang Hueber Antibody profiling for determination of patient responsiveness
EP2165194A4 (en) 2007-05-31 2010-09-08 Abbott Lab BIOMARKERS FOR PREDICTING RESPONSABILITY TO TNF ALPHA INHIBITORS IN AUTOIMMUNE DISEASES
SG182183A1 (en) 2007-06-08 2012-07-30 Biogen Idec Inc Biomarkers for predicting anti-tnf responsiveness or non-responsiveness
US7863021B2 (en) 2007-09-05 2011-01-04 Celera Corporation Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
WO2009102957A2 (en) 2008-02-14 2009-08-20 The Johns Hopkins University Methods to connect gene set expression profiles to drug sensitivity
WO2009117791A2 (en) 2008-03-28 2009-10-01 Katholieke Universiteit Leuven Mucosal gene signatures
KR20100003759A (ko) 2008-07-02 2010-01-12 양혜지 반짝이가 포함된 구두약
JP2012500993A (ja) 2008-08-25 2012-01-12 ヤンセン バイオテツク，インコーポレーテツド 潰瘍性大腸炎及び関連した疾患における抗ｔｎｆ処置のためのバイオマーカー
US20110191087A1 (en) 2008-09-03 2011-08-04 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Computer implemented model of biological networks
CA2737485A1 (en) 2008-10-10 2010-04-15 Mount Sinai Hospital Methods for classifying samples based on network modularity
JP5996429B2 (ja) 2009-09-03 2016-09-21 ジェネンテック， インコーポレイテッド 関節リウマチの治療、診断及びモニターするための方法
CA2777800C (en) 2009-10-15 2019-11-12 Crescendo Bioscience Biomarkers and methods for measuring and monitoring inflammatory disease activity
JP6073217B2 (ja) 2010-04-29 2017-02-08 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ゲノムモデルに関するデータ統合を用いたパスウェイ認識アルゴリズム（ｐａｒａｄｉｇｍ）
US10192641B2 (en) 2010-04-29 2019-01-29 The Regents Of The University Of California Method of generating a dynamic pathway map
WO2012066536A2 (en) 2010-11-16 2012-05-24 Prediguard Transcriptome signatures discriminate etanercept-treated rheumatoid arthritis (ra) patients according to their response or refractory status
EP2668287B1 (en) 2011-01-25 2017-09-06 TC LAND Expression Genes and genes combinations based on gene mknk1 predictive of early response or non response of subjects suffering from rheumatoid arthritis to tnf-alpha blocking monoclonal antibody
US20130040835A1 (en) 2011-05-05 2013-02-14 Exagen Diagnostics, Inc Genes predictive of anti-TNF response in inflammatory diseases
CA3295783A1 (en) 2011-05-10 2026-03-02 Prometheus Laboratories, Inc. Methods of disease activity profiling for personalized therapy management
US9416190B2 (en) 2012-09-27 2016-08-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Mesothelin antibodies and methods for eliciting potent antitumor activity
HU230680B1 (hu) 2012-10-19 2017-08-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Diagnosztikai eljárás
DK2914739T3 (da) 2012-11-05 2017-11-27 Novigenix Sa Kombinationer af biomarkører for kolorektale tumorer
CA2892490A1 (en) 2012-11-26 2014-05-30 Caris Science, Inc. Biomarker compositions and methods
US10161936B2 (en) 2013-03-08 2018-12-25 University Of Leipzig Method and kit for cytokine analysis from a human whole blood sample
US9945870B2 (en) 2013-05-17 2018-04-17 The Board Of Trustees Of The Leland Stanford Junior University Methods for determining responsiveness to an anti-CD47 agent
WO2015006213A1 (en) 2013-07-08 2015-01-15 Northeastern University Methods for identifying complex disease subtypes
US9387246B2 (en) 2013-09-03 2016-07-12 L. Douglas Graham Treatment methods for rheumatoid arthritis
WO2015084461A2 (en) 2013-09-23 2015-06-11 Northeastern University System and methods for disease module detection
JP7054990B2 (ja) 2014-03-27 2022-04-15 ジェネンテック， インコーポレイテッド 炎症性腸疾患の診断及び治療のための方法
CA2943821A1 (en) 2014-04-02 2015-10-08 Crescendo Bioscience Biomarkers and methods for measuring and monitoring juvenile idiopathic arthritis activity
WO2015164406A1 (en) 2014-04-21 2015-10-29 University Of South Florida Salivary inflammatory biomarkers associated with glycemic control and oral health
MX2017004742A (es) 2014-10-20 2017-07-20 Nestec Sa Métodos para la predicción de niveles de farmacos anti-tnf alfa y formación de autoanticuerpos.
JP2018504584A (ja) 2014-12-02 2018-02-15 ネステク ソシエテ アノニム 過敏性腸疾患患者を治療するためのベドリズマブの投与計画を確立する方法
HK1257443A1 (zh) * 2015-08-21 2019-10-18 The Children's Hospital Of Philadelphia 治疗具有dcr3或dcr3网络基因中的遗传变异的患者的自身免疫病症的方法
EP3356561B1 (en) * 2015-10-02 2021-10-27 Momenta Pharmaceuticals, Inc. Therapeutic and diagnostic methods for autoimmune diseases and/or inflammation
US10018637B2 (en) 2015-10-06 2018-07-10 Celgene International Ii Sarl Methods for treating inflammatory and other diseases and the use of biomarkers as predictors of clinical sensitivity to treatment with apremilast
ES2716900T3 (es) 2015-11-06 2019-06-17 Promise Advanced Proteomics Un método para cuantificar anticuerpos anti-TNF
US20190080051A1 (en) 2015-11-11 2019-03-14 Northeastern University Methods And Systems For Profiling Personalized Biomarker Expression Perturbations
US20170145501A1 (en) 2015-11-20 2017-05-25 Lasse Folkersen Apparatus and methods of using of biomarkers for predicting tnf-inhibitor response
EP3440579A4 (en) 2015-11-24 2020-03-25 Klaritos, Inc. INNOVATIVE MODEL OF DELIVERY, PROCESSING AND PAYMENT FOR SPECIALIZED MEDICINES
GB201521357D0 (en) 2015-12-03 2016-01-20 Univ Liverpool Methods for predicting response to anti-TNF therapy
JP6572120B2 (ja) 2015-12-14 2019-09-04 浜松ホトニクス株式会社 光ビーム照射装置
WO2017151755A1 (en) 2016-03-02 2017-09-08 Crescendo Bioscience Biomarkers and methods for predicting response to discontinuation of inflammatory disease therapy
WO2017223116A2 (en) 2016-06-20 2017-12-28 Healthtell Inc. Methods for differential diagnosis of autoimmune diseases
EP3654993A4 (en) 2017-07-17 2021-08-25 The Broad Institute, Inc. CELL ATLAS OF HEALTHY HUMAN COLUMN AND HUMAN COLUMN WITH COLITIS ULCEROSA
US20200165677A1 (en) 2017-07-18 2020-05-28 Thaddeus Stappenbeck Methods and uses of inflammatory bowel disease biomarkers
US10512775B2 (en) * 2017-08-30 2019-12-24 Cochlear Limited Noise reduction for implantable hearing prostheses
US20190287644A1 (en) 2018-02-15 2019-09-19 Northeastern University Correlation Method To Identify Relevant Genes For Personalized Treatment Of Complex Disease
WO2019178546A1 (en) 2018-03-16 2019-09-19 Scipher Medicine Corporation Methods and systems for predicting response to anti-tnf therapies
CA3119294A1 (en) 2018-11-15 2020-05-22 Janssen Biotech, Inc. Methods and compositions for prediction of response to a therapy of inflammatory bowel disease
WO2020198068A1 (en) 2019-03-22 2020-10-01 Inflammatix, Inc. Systems and methods for deriving and optimizing classifiers from multiple datasets
SG11202110655UA (en) 2019-03-28 2021-10-28 Phase Genomics Inc Systems and methods for karyotyping by sequencing
JP2022541125A (ja) 2019-06-27 2022-09-22 サイファー メディシン コーポレーション 患者を層別化するための分類子の開発
WO2022051245A2 (en) 2020-09-01 2022-03-10 Scipher Medicine Corporation Methods and systems for predicting response to anti-tnf therapies
EP4308732A4 (en) 2021-03-19 2025-02-26 Scipher Medicine Corporation METHODS FOR CLASSIFICATION AND TREATMENT OF PATIENTS
WO2023150731A2 (en) 2022-02-04 2023-08-10 Scipher Medicine Corporation Systems and methods for predicting response to anti-tnf therapies

Similar Documents

Publication Publication Date Title
GB2603294A (en) Developing classifiers for stratifying patients
JP7497084B2 (ja) がん治療の有効性を予測するためのシステムおよび方法
AU2016281766B2 (en) Epigenetic chromosome interactions
JP2021518432A5 (enExample)
GB2622147A (en) Methods of classifying and treating patients
Chadeau-Hyam et al. Prediagnostic transcriptomic markers of Chronic lymphocytic leukemia reveal perturbations 10 years before diagnosis
JP2021518432A (ja) 抗ｔｎｆ療法に対する応答性を予測するための方法及びシステム
EP4359567A1 (en) Methods and systems for therapy monitoring and trial design
Quintana-Duque et al. Predictors of remission, erosive disease and radiographic progression in a Colombian cohort of early onset rheumatoid arthritis: a 3-year follow-up study
US20250174366A1 (en) Methods and Compositions for Assessing and Treating Lupus
CN114929899A (zh) 一种新抗原的筛选方法、系统及其用途
JP2023538963A5 (enExample)
GB2616129A (en) Methods and systems for predicting response to anti-TNF therapies
Kakurina et al. Use of exploratory factor analysis to ascertain the correlation between the activities of rheumatoid arthritis and infection by human parvovirus B19
Knevel et al. Genomic influences on susceptibility and severity of rheumatoid arthritis
Coto-Segura et al. A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis
Song et al. Risk of venous thromboembolism in Korean patients with rheumatoid arthritis treated with Janus kinase inhibitors: A nationwide population-based study
Cappelli et al. Tocilizumab treatment leads to improvement in disease activity regardless of CCP status in rheumatoid arthritis
Ao et al. Cellular senescence-associated genes in rheumatoid arthritis: Identification and functional analysis
US20170145501A1 (en) Apparatus and methods of using of biomarkers for predicting tnf-inhibitor response
Hong et al. Differential DNA methylation 7 months after SARS-CoV-2 infection
EP4519878A2 (en) Methods for identifying shared biological pathways between diseases using mendelian randomization
CN117981011A (zh) 用于个体化疗法的方法和系统
Wang et al. Evaluation of Siltuximab and Tocilizumab Analytical Interference on Interleukin 6 Measurements
Capelusnik et al. POS0508 predictors of persistent disease in early arthritis: 12 months results